Cramer-Gesundheits-Consulting: PR successes

PR successes

Jenapharm

Jenapharm

Male hormone deficiency – a new indication established with PR

Sector:
Research-based Pharmaceutical industry

Client:
Jenapharm, Jena (now a subsidiary of Schering AG)

Communication task:
Communication of “climacterium virile” as a new indication.

Target groups:
Urologists
General practitioners and internists
Men from the age of 50 and their partners
Trade and lay media

Implementation and successes:
Intensive media work, over a three-year period creates an awareness of the issue and establish the concept of male hormone deficiency. Male hormone deficiency is presented as serious affection that requires treatment, the urologist is positioned as specialist for the syndrome. Empirical opinion research shows that the messages reached over half of the age group affected and the majority of physicians within three years.

Continuative links:
www.jenapharm.de

Back to the overview

Contact

Cramer PR im Gesundheits-
wesen und Consultant GmbH
Rathausplatz 12-14
65760 Eschborn
Tel: +49 (0)6196 - 77 66 - 0
Fax: +49 (0)6196 - 77 66 - 216
Contact

© 2012 CGC Cramer-Gesundheits-Consulting GmbH Website credits Sitemap Data protection